Telaprevir and VX-222 pair well in interferon-free regimen, VX-135 on the horizon
New fixed-dose combination pills measure up to Atripla - corrected version*
The generic generation
Are antiretroviral switch or simplification studies of benefit for patients?
First generic HIV drugs could save US at least $920 million a year
The road to PrEP: trials, regulation and roll-out
Tenofovir pro-drug GS-7340 shows good safety and efficacy in short study
